American Pharmacy News
  • People
  • Innovation
  • Regulatory
  • Industry
  • Federal Issues
  • State Issues
  • Directory
  • People
  • Innovation
  • Regulatory
  • Industry
  • Federal Issues
  • State Issues
  • Directory
  • Home
  • »
  • Stories
  • »
  • 2017
  • »
  • May

CVS Health opens MinuteClinic in nation's capital

American Pharmacy News Reports | May 1, 2017
The new clinic in Washington will be open weekdays with no appointments necessary.

CVS Health recently opened a MinuteClinic walk-in medical clinic inside the CVS Pharmacy store on K Street NW in Washington D.C. Read More »

Shire publishes results of lanadelumab study in New England Journal of Medicine

American Pharmacy News Reports | May 1, 2017
In this Phase 1b study, no serious adverse events or discontinuations due to adverse events were observed at all doses studied.

Shire PLC has published results from its Phase 1b lanadelumab study in the New England Journal of Medicine. Read More »

Purdue Pharma welcomes new OTC business lead

American Pharmacy News Reports | May 1, 2017
Carrie Chomiak will work with the company's OTC assets, development, implementation, communication and more.

Purdue Pharma LP's Carrie Chomiak will be stepping up into a substantial business role as lead of over-the-counter product franchise for brands including Betadine microbicide antiseptics, Slow-Mag magnesium chloride supplements, Senokot laxative and Colace stool softener. Read More »

Biologics chosen as specialty pharmacy provider for ZEJULA

Carrie Bradon | May 1, 2017
The American Cancer Society states that there are more than 22,000 women who will be diagnosed with ovarian cancer this year.

Biologics Inc., a McKesson Specialty Health oncology pharmacy services company, has been chosen by Tesaro Inc. to provide its new drug. Read More »

Pharmacy Benefits Managers can be more affordable option than drugstores

American Pharmacy News Reports | May 1, 2017
The new agenda of drugstores would seek to increase their profit, while costing consumers more.

The Pharmaceutical Care Management Association is beginning the DrugBenefitSolutions national campaign, in which it seeks to explain how pharmacy benefits managers are helping to reduce the price of medications and assist consumers, as well as employers and unions. Read More »

Whistleblowers encouraged to deliver accurate information

American Pharmacy News Reports | May 2, 2017
Whistleblowing could prevent injuries and yield rewards for individuals.

The Corporate Whistleblower Center is encouraging individuals to reach out to authorities if they know of unsanitary pharmacy practices. Read More »

Martin to join Purdue Pharma as VP of corporate affairs

Carrie Bradon | May 2, 2017
Josie Martin has held positions at Ketchum, the Federation of American Hospitals and the American Red Cross.

Josie Martin has been named vice president of corporate affairs and communications for Purdue Pharma LP. Read More »

Kmart Pharmacy offers reduced pricing for epinephrine pens

American Pharmacy News Reports | May 2, 2017
The generic version of Adrenaclick is now available for free for patients with commercial insurance.

To make health care more affordable for those who need it, Kmart Pharmacy is reducing the price of epinephrine auto-injector pens. Read More »

New medication from Teva available for asthma treatment

American Pharmacy News Reports | May 2, 2017
AirDuo RespiClick was approved by the FDA in January in three dosage options: 55/14 mcg, 113/14 mcg and 232/14 mcg.

Teva Pharmaceutical Industries Ltd. has launched AirDuo RespiClick, an inhalation powder for the treatment of asthma in patients 12 and older. Read More »

Amgen, Novartis seek cure for Alzheimer's-related migraines

American Pharmacy News Reports | May 2, 2017
Amgen will receive payments from Novartis beginning this year, as the companies share costs.

Amgen and Novartis are working together to fight against migraines with erenumab, an expanded commercial collaboration building on a global neuroscience collaboration in Alzheimer's disease and migraine established in 2015. Read More »

DelMar decreases public holdings by $700,000

American Pharmacy News Reports | May 3, 2017
DelMar intends to use the net proceeds from the offering for general corporate purposes.

DelMar Pharmaceuticals Inc., a company fighting for cancer patients and therapies, decreased its public stock aggregate share from 2.77 million to 2.08 million this month. Read More »

Biopharma Corp. wraps up latest acne product trial

American Pharmacy News Reports | May 3, 2017
BPX-01[1] is a “non-oil-based topical gel with fully solubilized minocycline.

BioPharmX Corp., a leading pharmaceutical company developing and promoting health products for the dermatology and women’s market, revealed it has completed the “last subject visit in its Phase 2b trial,” as of March. Read More »

PharmaCyte Biotech to receive 2017 Buzz of BIO award

Carrie Bradon | May 3, 2017
Among topics to be discussed will be drug discovery, biomanufacturing, biofuels and cell therapy.

PharmaCyte Biotech, Inc., announced that they would be winning the 2017 Buzz of BIO "Pipelines of Promise" award prior to the 2017 BIO International Convention. Read More »

Lineup announced for May 16-18 pharmaceutical convention

American Pharmacy News Reports | May 3, 2017
Magid Abou-GharbiaMoulder, from the Temple University School of Pharmacy, will present

The biggest pharmaceutical event series in the world, the CPhl, will take place May 16-18 in Philadelphia and feature over 55 speakers. Read More »

Genentech sees promising results in carcinoma drug's Phase II study

American Pharmacy News Reports | May 5, 2017
These Phase II results support the scientific rationale for potentially combining TECENTRIQ and Avastin in people with this type of kidney cancer.

Genentech, a member of the Roche Group, recently announced its Phase II IMmotion150 study delivered promising results. Read More »

Purdue Pharma promotes Barton to general counsel

American Pharmacy News Reports | May 5, 2017
Maria Barton, a vice president at the company, will also become a member of the executive committee.

Purdue Pharma L.P.'s Maria Barton has been promoted from deputy general counsel to general counsel. Read More »

Amgen's Repatha approved for single-dose delivery option in Europe

American Pharmacy News Reports | May 6, 2017
The drug will have centralized marketing authorization in 28 countries in the European Union.

The European Commission has adopted a decision to change the Repatha (evolocumab) marketing authorization, approving a new single-dose delivery option. Read More »

Pfizer releases results from ORAL Strategy study of Xeljanz

American Pharmacy News Reports | May 6, 2017
The study found that XELJANZ 5mg plus MTX demonstrated non-inferiority vs. Humira plus MTX.

Pfizer Inc. recently released top-line results for ORAL Strategy, a Phase 3B/4 study of XELJANZ (tofacitinib citrate) 5mg twice daily in the treatment of moderate to severe rheumatoid arthritis. Read More »

AbbVie's eight-week Viekirax + Exviera program gets positive reviews

American Pharmacy News Reports | May 6, 2017
The Viekirax + Exviera treatment is approved as a 12-week treatment in the European Union for GT1b chronic HCV-infected patients.

AbbVie, a global biopharmaceutical company, recently announced its Viekirax + Exviera eight-week treatment program has been granted a positive opinion by the European Committee for Medicinal Products for Human Use of the European Medicines Agency. Read More »

FDA accepts Mylan's application for MYL-1401H

American Pharmacy News Reports | May 6, 2017
The proposed drug will add to the company’s expansive oncology portfolio.

Mylan's Biologics License Application for MYL-1401H, a proposed biosimilar to Neulasta (pegfilgrastim), has been accepted by the U.S. Food and Drug Administration. Read More »

  • «
  • 1 (current)
  • 2
  • 3
  • 4
  • 5
  • »
Trending

Dr. Allison Hill DC State Board of Pharmacy Chairperson

Modified services and closures announced for DC Emancipation Day observance

 Jeff Harrell Board President

Arkansas law bans PBMs from pharmacy ownership to curb anti-competitive practices

Shaun Noorian, Founder, CEO & Chairman, Empower Pharmacy

Empower Pharmacy ranks among fastest-growing private firms in Southwest

 Jeff Harrell Board President

NCPA reacts to Trump's drug pricing executive order targeting pharmacy benefit managers

Copyright © 2025 American Pharmacy News. All Rights Reserved.

  • About
  • Contact
  • Privacy Policy
  • Terms of Service

Alerts Sign-up